Skip to main content
Equibles

SYMBIOTEC · Symbiotec Pharmalab Limited · Documents

Use SYMBIOTEC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SYMBIOTEC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,611.30 INR -31.10 (-1.89%) At close · Nov 13
Rebalance outlook locked
Market Cap
103.54B INR
Shares
64.26M
Volume · Nov 13 271.82K Avg daily vol (51 sessions) 1.98M

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call New Q2 2027 earnings call Held Nov 6, 2026
2026
Sep 22
Earnings call
Q1 2027 earnings call

Symbiotec Pharmalab Limited reported Q1 FY27 revenue of INR218 crores, up 7% year-on-year, EBITDA of INR45 crores and net profit of about INR14 crores. FY27 targets 20% revenue and 25% EBITDA growth; new-business revenues expected in 6 to 12 months.

Showing 1–2 of 2 documents